Edmund Dunn's most recent trade in Monte Rosa Therapeutics Inc was a trade of 2,062 Common Stock done at an average price of $4.4 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 03 Jun 2025 | 2,062 | 23,732 | - | 4.4 | 9,174 | Common Stock |
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 53,400 | 53,400 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 11,850 | 25,794 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.83 per share. | 05 Jul 2024 | 1,610 | 13,944 | - | 3.8 | 6,166 | Common Stock |
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.04 per share. | 03 Jun 2024 | 1,207 | 15,554 | - | 4.0 | 4,876 | Common Stock |
| Monte Rosa Therapeutics Inc | Dunn Edmund | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Edmund Dunn | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |